Zheng, Adi <br/><br/>
Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction.  [electronic resource] 

 -  Current cancer drug targets  2014 
 - 156-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/1568009613666131126115444  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis--drug effects<br/>Cell Proliferation--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>Curcumin--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Endoplasmic Reticulum Stress--drug effects<br/>Female<br/>HCT116 Cells<br/>Humans<br/>Inhibitory Concentration 50<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mitochondria--drug effects<br/>Necrosis<br/>Oxidative Stress--drug effects<br/>Phytotherapy<br/>Plants, Medicinal<br/>Reactive Oxygen Species--metabolism<br/>S Phase Cell Cycle Checkpoints--drug effects<br/>Time Factors<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays